Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
27 December 2007Website:
http://www.infusystem.comNext earnings report:
14 March 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 21:03:57 GMTDividend
Analysts recommendations
Institutional Ownership
INFU Latest News
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Appoints Ronald Hundzinski to the Board of Directors.
InfuSystem Holdings, Inc. (NYSE:INFU ) Q3 2024 Results Conference Call November 7, 2024 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Jim Sidoti - Sidoti & Company Brooks O'Neil - Lake Street Capital Markets Kyle Bauser - B. Riley Securities Matt Hewitt - Craig-Hallum Capital Group Aaron Warwick - Breakout Investors Operator Good day, and welcome to the InfuSystem Third Quarter of 2024 Financial Results Conference Call.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024.
The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid technological advancements powered by advanced artificial intelligence (AI) and biotechnology.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024.
FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara's joint venture partner InfuSystem Holdings, Inc., announced today the execution of an exclusive United States distribution agreement with, and minority investment in, ChemoMouthpiece, LLC (“ChemoMouthpiece”).
InfuSystem Holdings, Inc. (NYSE:INFU ) Q2 2024 Earnings Call Transcript August 8, 2024 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Matt Hewitt - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings, Inc. Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024.
InfuSystem stock has not performed well compared to the S&P 500, but the company has made significant investments that are expected to pay off in 2024 and beyond. The company's struggles over the past two years were due to making investments that will be monetized in 2024 and beyond. INFU's biomed and wound care businesses are expected to drive growth in 2024, with opportunities for expansion and increased profitability.
InfuSystem Holdings Inc. (NYSE:INFU ) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Richard DiIorio - CEO Barry Steele - CFO Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alexander Nowak - Craig-Hallum Capital Group James Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings Inc. First Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note that today's event is being recorded.
What type of business is InfuSystem Holdings?
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
What sector is InfuSystem Holdings in?
InfuSystem Holdings is in the Healthcare sector
What industry is InfuSystem Holdings in?
InfuSystem Holdings is in the Medical Instruments & Supplies industry
What country is InfuSystem Holdings from?
InfuSystem Holdings is headquartered in United States
When did InfuSystem Holdings go public?
InfuSystem Holdings initial public offering (IPO) was on 27 December 2007
What is InfuSystem Holdings website?
https://www.infusystem.com
Is InfuSystem Holdings in the S&P 500?
No, InfuSystem Holdings is not included in the S&P 500 index
Is InfuSystem Holdings in the NASDAQ 100?
No, InfuSystem Holdings is not included in the NASDAQ 100 index
Is InfuSystem Holdings in the Dow Jones?
No, InfuSystem Holdings is not included in the Dow Jones index
When was InfuSystem Holdings the previous earnings report?
No data
When does InfuSystem Holdings earnings report?
The next expected earnings date for InfuSystem Holdings is 14 March 2025